| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.344 | 7.394 | 7.216 | 8.008 | 8.164 | 6.746 | 15.374 | 10.269 | 10.011 | 11.855 |
| Total Income - EUR | 7.344 | 7.394 | 7.216 | 8.008 | 8.164 | 6.746 | 17.396 | 10.275 | 10.016 | 11.857 |
| Total Expenses - EUR | 4.457 | 4.538 | 5.814 | 4.705 | 5.238 | 3.767 | 5.534 | 3.145 | 12.472 | 11.048 |
| Gross Profit/Loss - EUR | 2.887 | 2.856 | 1.402 | 3.303 | 2.925 | 2.979 | 11.862 | 7.129 | -2.457 | 809 |
| Net Profit/Loss - EUR | 2.667 | 2.634 | 1.186 | 3.063 | 2.680 | 2.777 | 11.340 | 6.821 | -2.557 | 453 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Med Esculap S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.874 | 3.616 | 3.193 | 4.203 | 3.643 | 4.338 | 12.171 | 11.875 | 8.205 | 4.098 |
| Inventories | 1.509 | 1.726 | 1.697 | 1.919 | 1.882 | 2.023 | 2.421 | 2.429 | 1.814 | 1.804 |
| Receivables | 95 | 94 | 97 | 147 | 0 | 87 | 0 | 0 | 0 | 0 |
| Cash | 2.270 | 1.795 | 1.399 | 2.137 | 1.761 | 2.227 | 9.750 | 9.447 | 6.390 | 2.294 |
| Shareholders Funds | 497 | 492 | 454 | 3.509 | 43 | 42 | 41 | 6.862 | 848 | 1.296 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.378 | 3.124 | 2.739 | 694 | 3.600 | 4.296 | 12.130 | 5.013 | 7.357 | 2.802 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Med Esculap S.r.l.